A. Spanevello (Milan, Italy), B. Lipworth (Dundee (Angus), United Kingdom)
Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control
M. Castro (St. Louis, United States of America), C. Humphries (Charlotte, United States of America), A. White (Port Orange, United States of America), C. Fox (Buffalo, United States of America), A. Rutgersson (Gothenburg, Sweden), M. Jörnten-Karlsson (Gothenburg, Sweden), B. Dutta (Gaithersburg, United States of America), L. Hagger (Gaithersburg, United States of America)
|    |
Prevalence of abnormal lung function and age-dependent risk factors in the general population
A. Ofenheimer (Maastricht, Netherlands), M. Breyer (Vienna, Austria), S. Hartl (Vienna, Austria), O. Burghuber (Vienna, Austria), A. Agusti (Barcelona, Spain), R. Faner (Barcelona, Spain), A. Schrott (Vienna, Austria), M. Urban (Vienna, Austria), R. Breyer-Kohansal (Vienna, Austria)
| |
Relationship of airway structural changes and lung function abnormalities with blood and BAL biomarkers in asthma
S. Bazan-Socha (Krakow, Poland), J. Zuk (Krakow, Poland), P. Kozlik (Krakow, Poland), J. Zarychta (Zakopane, Poland), K. Okon (Krakow, Poland), L. Zareba (Rzeszow, Poland), J. Bazan (Rzeszow, Poland), J. Soja (Krakow, Poland), J. Musial (Krakow, Poland)
| |
Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study
S. Shin (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), D. Kang (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), M. Kang (Seoul, Republic of Korea), S. Kong (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), J. Cho (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea)
|  |
PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ACCORDING TO STRENGTH IN UPPER LIMBS
M. Churruca Arrospide (Madrid, Spain), A. Roca Noval (Madrid, Spain), E. Vázquez Espinosa (Madrid, Spain), T. Alonso Pérez (Madrid, Spain), P. Pérez González (Madrid, Spain), R. Gómez Punter (Madrid, Spain)
| |
Health status impact on mortality and lung function decline in COPDGene smokers
W. Labaki (Ann Arbor, United States of America), T. Gu (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), J. Curtis (Ann Arbor, United States of America), X. Soler (San Diego, United States of America), S. Bhatt (Birmingham, United States of America), J. Bon (Pittsburgh, United States of America), T. Beaty (Baltimore, United States of America), J. Hokanson (Aurora, United States of America), D. Curran-Everett (Denver, United States of America), K. Lowe (Denver, United States of America), R. Bowler (Denver, United States of America), B. Make (Denver, United States of America), E. Regan (Denver, United States of America), F. Martinez (New York, United States of America), C. Hersh (Boston, United States of America), E. Silverman (Boston, United States of America), J. Crapo (Denver, United States of America), M. Han (Ann Arbor, United States of America)
| |
Is the course of handgrip strength an indicator for mortality in COPD? A longitudinal cohort study
D. Kohlbrenner (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), R. Thurnheer (Muensterlingen, Switzerland), J. Leuppi (Liestal, Switzerland), S. Irani (Aarau, Switzerland), M. Frey (Barmelweid, Switzerland), M. Brutsche (St. Gallen, Switzerland), T. Brack (Glarus, Switzerland), M. Kohler (Zurich, Switzerland), C. Clarenbach (Zurich, Switzerland)
| |
Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the German COSYCONET cohort.
F. Trudzinski (Homburg, Germany), K. Kahnert (Munich , Germany), C. Vogelmeier (Marburg , Germany), P. Alter (Marburg , Germany), F. Seiler (Homburg , Germany), S. Fähndrich (Freiburg , Germany), H. Watz (Grosshansdorf , Germany), T. Welte (Hannover , Germany), T. Speer (Homburg , Germany), S. Zewinger (Homburg , Germany), F. Biertz (Hannover , Germany), H. Kauczor (Heidelberg , Germany), R. Jörres (Munich , Germany), R. Bals (Homburg , Germany)
| |